JAZZ Overview
Upcoming Projects (JAZZ)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (JAZZ)
-
Quarterly Survey: Narcolepsy & Oxybate Treatments including Avadel’s Lumryz October 2024
Tickers: AVDL, JAZZ, AMRX, ABEV
Executed On: Oct 24, 2024 at 04:41 PM EDT -
Discussing the Updated Phase 2 Data for Zanidatamab Demonstrating Increased mPFS in HER2-Positive Metastatic Gastroesophageal Adenocarcinoma at ESMO 2024
Tickers: ZYME, JAZZ, BGNE
Executed On: Oct 11, 2024 at 04:30 PM EDT -
Quarterly Survey: Narcolepsy & Oxybate Treatments including Avadel’s Lumryz July 2024
Tickers: AVDL, JAZZ, AMRX, ABEV
Executed On: Jul 23, 2024 at 01:58 PM EDT -
Discussing the recent data from Takeda's phase 2b trial of TAK-861 as a treatment for patients with narcolepsy.
Tickers: TAK, JAZZ
Executed On: Jun 07, 2024 at 12:00 PM EDT -
Quarterly Survey: Narcolepsy & Oxybate Treatments including Avadel’s Lumryz April 2024
Tickers: AVDL, JAZZ, AMRX, ABEV
Executed On: Apr 22, 2024 at 04:22 PM EDT -
Discussing Avadel's LUMRYZ (sodium oxybate) for the Treatment of Narcolepsy with a Prescriber
Tickers: AVDL, JAZZ
Executed On: Feb 15, 2024 at 12:30 PM EST -
Quarterly Survey: Narcolepsy Oxybate Treatments and Avadel’s Lumryz January 2024
Tickers: AVDL, JAZZ, AMRX, ABEV
Executed On: Jan 19, 2024 at 04:24 PM EST -
A Second Look: Discussing Recent Clinical Data on Jazz Pharmaceuticals' Xywav and Avadel's LUMRYZ (sodium oxybate) for the Treatment of Narcolepsy
Tickers: AVDL, JAZZ
Executed On: Nov 08, 2023 at 02:30 PM EST -
Discussing Recent Clinical Data on Jazz Pharmaceuticals' Xywav and Avadel's LUMRYZ (sodium oxybate) for the Treatment of Narcolepsy
Tickers: JAZZ, AVDL
Executed On: Nov 07, 2023 at 10:00 AM EST -
Quarterly Survey: Narcolepsy Oxybate Treatments and Avadel’s Lumryz October 2023
Tickers: AVDL, JAZZ
Executed On: Oct 26, 2023 at 03:35 PM EDT -
A Second Opinion: Discussing the prescribing patterns of LUMRYZ (sodium oxybate) for Cataplexy or Excessive Daytime Sleepiness in Adults with Narcolepsy
Tickers: AVDL, JAZZ
Executed On: Aug 23, 2023 at 04:00 PM EDT -
Discussing the prescribing patterns of LUMRYZ (sodium oxybate) for Cataplexy or Excessive Daytime Sleepiness in Adults with Narcolepsy
Tickers: AVDL, JAZZ
Executed On: Aug 16, 2023 at 04:30 PM EDT -
Checking in on the treatment landscape for AML and the use of Vyxeos (cytarabine and daunorubicin) from Jazz Pharmaceuticals.
Ticker: JAZZ
Executed On: Aug 11, 2023 at 02:00 PM EDT -
Quarterly Survey: Narcolepsy Oxybate Treatments / Avadel’s Lumryz July 2023
Tickers: AVDL, JAZZ
Executed On: Jul 24, 2023 at 04:40 PM EDT -
Quarterly Survey_Narcolepsy and Avadel’s Lumryz April 2023
Tickers: AVDL, JAZZ
Executed On: Apr 14, 2023 at 03:36 PM EDT -
A look at potential therapies in essential tremor, including PRAX-944 (T-type calcium channel blocker) and Suvecaltamide
Tickers: PRAX, JAZZ
Executed On: Nov 10, 2022 at 03:15 PM EST -
As the approval for FT218 continues to be delayed, we discuss its market potential with a prescriber of Xyrem/Xywav
Ticker: JAZZ
Executed On: Mar 23, 2022 at 02:00 PM EDT
Expired Projects (JAZZ)
-
Quarterly Survey: Narcolepsy and Oxybate Treatments including Avadel’s Lumryz April 2024
Tickers: AVDL, JAZZ, AMRX, ABEV
Execute By: Apr 23, 2024 -
LUMRYZ LAUNCH PERFORMANCE & OUTLOOK SURVEY
Tickers: AVDL, JAZZ
Execute By: Jul 21, 2023 -
With multiple options available for Dravet and Lennox Gastaut patients, how are prescribers changing practice?
Tickers: JAZZ, ZGNX
Execute By: Oct 15, 2021 -
Legal opinion: Will Avadel be able to launch FT218 in a timely manner (YE21/early 2022)?
Tickers: AVDL, JAZZ
Execute By: Dec 11, 2020
Upcoming & Overdue Catalysts (JAZZ)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (JAZZ)
-
Phase 1/2 presentation of Jazz Pharma's (JAZZ) CPX-351 in Acute myeloid leukemia expected at ASCO May 31, 2019, 3:45 p.m. CT
Ticker: JAZZ
Occurred on: Jun 01, 2019 -
Flamel Technologies(FLML) targets filing an NDA for once-nightly sodium oxybate using Micropump technology in the first half of 2017
Tickers: FLML, JAZZ
Occurred on: May 01, 2018 -
Jazz Pharmaceuticals (JAZZ) Presents at the Wells Fargo Securities Healthcare Conference
Ticker: JAZZ
Occurred on: Sep 06, 2017 -
Patient Enrollment is Complete for the Phase 3 Studies of JZP-110 Evaluating Excessive Sleepiness in Obstructive Sleep Apnea
Ticker: JAZZ
Occurred on: Sep 26, 2016 -
Jazz Pharma to update investors on wake-promoting agent JZP-110 on June 20
Ticker: JAZZ
Occurred on: Jun 20, 2016
Strategic Initiatives (JAZZ)
-
Jazz (Jazz) to acquire GW Pharmaceuticals (GWPH) for $7.2 billion
Tickers: JAZZ, GWPH
Announcement Date: Feb 03, 2021 -
Jazz Pharmaceuticals (JAZZ) Acquires SpringWorks Therapeutics' (SWTX) FAAH Inhibitor Program for post-traumatic stress disorder
Tickers: JAZZ, SWTX
Announcement Date: Oct 26, 2020 -
Jazz Pharmaceuticals plc Announces Results of Tender Offer to Purchase All of The Outstanding Shares of Common Stock of Celator Pharmaceuticals, Inc.
Tickers: JAZZ, CPXX
Announcement Date: Jul 12, 2016 -
Jazz Pharmaceuticals Announces Expiration of HSR Waiting Period for Proposed Celator Pharmaceuticals, Inc. Acquisition
Tickers: JAZZ, CPXX
Announcement Date: Jun 24, 2016 -
Jazz Pharmaceuticals And Celator Pharmaceuticals Announce Agreement For Jazz Pharmaceuticals To Acquire Celator For $30.25 Per Share
Tickers: JAZZ, CPXX
Announcement Date: May 31, 2016
